Lipids
Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(543)
- Endocannabinoid/Endocannabinoid-like(145)
- Fatty Acid Conjugates(11)
- Fatty Acids(498)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(77)
- Fatty Esters/Ethers(152)
- Glycerolipids(357)
- Glycerophospholipids(272)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(146)
- Isoprostanes(36)
- Leukotrienes(69)
- Lipid Transport(11)
- Lipid-Based Drug Delivery(163)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(124)
- Other Lipid Kinases(2)
- P450
- Polyketides(71)
- Prenol Lipids(19)
- Prostaglandins(483)
- Protein Lipidation(24)
- Reactive O2/N2 Pathways(116)
- Saccharolipids(2)
- Sphingolipids(359)
- Sterol Lipids(288)
- Thromboxanes(14)
- 11β-HSD
- 17β-HSD(2)
Lipids 相关产品(3019)
- GC4186210(E),12(Z)-Conjugated Linoleic Acid methyl esterCAS: 21870-97-3纯度: >98.00%
A conjugated linoleic acid methyl ester
- GC4187010-PAHSA 13C4CAS: 2705244-93-3纯度: >95.00%
An internal standard for the quantification of 10-PAHSA
- GC4187411(Z),14(Z),17(Z)-Eicosatrienoic Acid methyl esterCAS: 62472-96-2纯度: >98.00%
An ester form of the ω-3 PUFA
- GC4187511(Z),14(Z)-Eicosadienoic Acid methyl esterCAS: 61012-46-2纯度: >98.00%
A more lipid soluble form of 11(Z),14(Z)-eicosadienoic acid
- GC4187611(Z)-Eicosenoic Acid methyl esterCAS: 2390-09-2纯度: >98.00%
A natural derivative of 11(Z)-eicosenoic acid
- GC4187911-deoxy-11-methylene-15-keto Prostaglandin D2CAS: 958759-75-6纯度: >98.00%
Stable ligand for the DP 1 receptor
- GC4188011-keto FluprostenolCAS: 62145-07-7纯度: >98.00%
A prostaglandin D 2 /Fluprostenol structural hybrid
- GC4188412(Z),15(Z)-Heneicosadienoic AcidCAS: 191545-08-1纯度: >98.00%
A very long-chain polyunsaturated fatty acid
- GC4188912-oxo Stearic Acid methyl esterCAS: 2380-27-0纯度: >98.00%
An esterified form of 12-oxo stearic acid
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC41862 | 10(E),12(Z)-Conjugated Linoleic Acid methyl ester | 21870-97-3 | >98.00% | |
A conjugated linoleic acid methyl ester | ||||
| GC41864 | 10,13-epoxy-10,12-Octadecadienoic Acid | 4179-43-5 | >98.00% | |
A furan fatty acid | ||||
| GC41867 | 10-Nitrolinoleate | 774603-04-2 | >95.00% | |
A nitrated fatty acid and PPARγ agonist | ||||
| GC41868 | 10-Nitrooleate | 875685-46-4 | >98.00% | |
A novel endogenous lipid signalling molecule | ||||
| GC41869 | 10-OAHSA | 2005487-34-1 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41870 | 10-PAHSA 13C4 | 2705244-93-3 | >95.00% | |
An internal standard for the quantification of 10-PAHSA | ||||
| GC41871 | 10-POHSA | - | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41872 | 10-SAHSA | 2320261-81-0 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41873 | 10-Thiastearic Acid | 105099-89-6 | >98.00% | |
A stearoyl CoA desaturase inhibitor | ||||
| GC41874 | 11(Z),14(Z),17(Z)-Eicosatrienoic Acid methyl ester | 62472-96-2 | >98.00% | |
An ester form of the ω-3 PUFA | ||||
| GC41875 | 11(Z),14(Z)-Eicosadienoic Acid methyl ester | 61012-46-2 | >98.00% | |
A more lipid soluble form of 11(Z),14(Z)-eicosadienoic acid | ||||
| GC41876 | 11(Z)-Eicosenoic Acid methyl ester | 2390-09-2 | >98.00% | |
A natural derivative of 11(Z)-eicosenoic acid | ||||
| GC41877 | 11-dehydro Thromboxane B3 | 129228-55-3 | >98.00% | |
A urinary metabolite of TXA 3 | ||||
| GC41878 | 11-dehydro-2,3-dinor Thromboxane B2 | 79250-60-5 | >98.00% | |
A TXB 2 urinary metabolite | ||||
| GC41879 | 11-deoxy-11-methylene-15-keto Prostaglandin D2 | 958759-75-6 | >98.00% | |
Stable ligand for the DP 1 receptor | ||||
| GC41880 | 11-keto Fluprostenol | 62145-07-7 | >98.00% | |
A prostaglandin D 2 /Fluprostenol structural hybrid | ||||
| GC41882 | 12(S)-HETrE | 72710-10-2 | >98.00% | |
An inhibitor of platelet activation | ||||
| GC41884 | 12(Z),15(Z)-Heneicosadienoic Acid | 191545-08-1 | >98.00% | |
A very long-chain polyunsaturated fatty acid | ||||
| GC41885 | 12:0 N-Biotinyl Fatty Acid | 135447-73-3 | >98.00% | |
A biotinylated form of lauric acid | ||||
| GC41886 | 12-Doxylstearic Acid | 29545-47-9 | >95.00% | |
A hydrophobic spin label | ||||
| GC41887 | 12-OAHSA | 101901-73-9 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41889 | 12-oxo Stearic Acid methyl ester | 2380-27-0 | >98.00% | |
An esterified form of 12-oxo stearic acid | ||||
| GC41890 | 12-POHSA | 2042646-31-9 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41891 | 12-SAHSA | 51350-61-9 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||